Therapy Areas: Cardiovascular
Open Stent Solution concludes EUR2.5m seed financing round
28 September 2021 -

France-based MedTech start-up company Open Stent Solution (OSS) stated on Tuesday that it has raised EUR2.5m from its seed financing round.

Open Stent Solution said its funding round was led by Angels Santé, a French health business angel network, BeAngels, a Belgian business angel network, Bpifrance, the French government agency and private investors of cardiologists and cardiac surgeons.

The funding will support the development of Open Stent Solution's ribbon-shaped stented mitral valve for transcatheter replacement. Its breakthrough device is the first-ever open-stent heart valve and the only device bearing the promise to implant large size mitral valves through small delivery systems, comparable in size to best-in-class TAVI (transcatheter aortic valve implantation).

There are currently no devices approved for transfemoral or transeptal transcatheter mitral valve replacement (TMVR). Today, most patients with severe mitral regurgitation are unsuitable for open heart surgery and cannot have their valves replaced.



Related Headlines